HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $67,000 | +13.6% | 912 | 0.0% | 0.02% | +18.8% |
| Q2 2022 | $59,000 | +3.5% | 912 | 0.0% | 0.02% | +23.1% |
| Q1 2022 | $57,000 | +18.8% | 912 | 0.0% | 0.01% | +18.2% |
| Q4 2021 | $48,000 | -25.0% | 912 | 0.0% | 0.01% | -31.2% |
| Q3 2021 | $64,000 | +6.7% | 912 | 0.0% | 0.02% | +6.7% |
| Q2 2021 | $60,000 | -40.6% | 912 | 0.0% | 0.02% | -46.4% |
| Q1 2021 | $101,000 | -6.5% | 912 | 0.0% | 0.03% | -15.2% |
| Q4 2020 | $108,000 | +36.7% | 912 | 0.0% | 0.03% | +17.9% |
| Q3 2020 | $79,000 | -2.5% | 912 | 0.0% | 0.03% | -6.7% |
| Q2 2020 | $81,000 | -2.4% | 912 | 0.0% | 0.03% | -23.1% |
| Q1 2020 | $83,000 | -21.0% | 912 | 0.0% | 0.04% | +11.4% |
| Q4 2019 | $105,000 | -7.1% | 912 | 0.0% | 0.04% | -14.6% |
| Q3 2019 | $113,000 | +3.7% | 912 | 0.0% | 0.04% | 0.0% |
| Q2 2019 | $109,000 | – | 912 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |